Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Adverse Limb Events”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT01691911
What this trial is testing

Preconditioning Shields Against Vascular Events in Surgery

Who this might be right for
Abdominal Aortic AneurysmCarotid AtherosclerosisCritical Lower Limb Ischaemia
Mid Western Regional Hospital, Ireland 200
Not applicableActive Not RecruitingNCT04238546
What this trial is testing

Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty

Who this might be right for
Peripheral Arterial Disease
Nils Kucher 1,200
Not applicableUnknownNCT05852197
What this trial is testing

Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD

Who this might be right for
Anticoagulant DrugsAntiplatelet DrugPeripheral Arterial Disease
First Affiliated Hospital of Zhejiang University 6,000
Not applicableUnknownNCT02097186
What this trial is testing

Preconditioning Shields Against Vascular Events in Surgery

Who this might be right for
Abdominal Aortic AneurysmCarotid AtherosclerosisCritical Lower Limb Ischaemia
Mid Western Regional Hospital, Ireland 400
Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Not applicableLooking for participantsNCT06318767
What this trial is testing

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Who this might be right for
Major Adverse Limb EventsMajor Adverse Cardiovascular EventsPeripheral Artery Disease+2 more
Centre Hospitalier Universitaire, Amiens 134
Testing effectiveness (Phase 2)Study completedNCT06795698
What this trial is testing

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.

Who this might be right for
Fractures, BoneCKD Stage 4CKD Stage 3+4 more
Hospital Civil de Guadalajara 61
Not applicableUnknownNCT05362266
What this trial is testing

Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization

Who this might be right for
Major Adverse Cardiac EventsAdverse Effect of Unspecified General Anesthetic
Mahidol University 240
Not applicableNot Yet RecruitingNCT06979284
What this trial is testing

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Who this might be right for
Peripheral Arterial Disease(PAD)Chronic Limb Threatening IschemiaIntravascular Ultrasound+2 more
Hamilton Health Sciences Corporation 772
Not applicableStudy completedNCT03746275
What this trial is testing

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Who this might be right for
Atherosclerosis
Bayer 5,798
Post-approval studies (Phase 4)Looking for participantsNCT06909565
What this trial is testing

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Who this might be right for
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University 6,000